Literature DB >> 8043515

The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane.

T Lithgow1, R van Driel, J F Bertram, A Strasser.   

Abstract

The protein product of the oncogene bcl-2 is a potent inhibitor of apoptotic cell death. The Bcl-2 protein has variously been reported to reside in the nuclear envelope and endoplasmic reticulum or exclusively in the inner membrane of mitochondria. We therefore undertook a detailed analysis of the intracellular distribution of Bcl-2 by immunofluorescence, immunogold electron microscopy, and subcellular fractionation in three mouse cell lines expressing a human bcl-2 transgene and measured its importation into isolated mitochondria. By these methods, the protein was localized to the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Any proposal for the mechanism by which Bcl-2 inhibits apoptosis must therefore accommodate the fact that Bcl-2 localizes to cytoplasmic membranes facing the cytosol.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043515

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  56 in total

1.  More than one way to go.

Authors:  A H Wyllie; P Golstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

2.  Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints.

Authors:  S Conus; T Kaufmann; I Fellay; I Otter; T Rossé; C Borner
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

Review 3.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

4.  Activation of membrane-associated procaspase-3 is regulated by Bcl-2.

Authors:  J F Krebs; R C Armstrong; A Srinivasan; T Aja; A M Wong; A Aboy; R Sayers; B Pham; T Vu; K Hoang; D S Karanewsky; C Leist; A Schmitz; J C Wu; K J Tomaselli; L C Fritz
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

5.  Targeting and insertion of C-terminally anchored proteins to the mitochondrial outer membrane is specific and saturable but does not strictly require ATP or molecular chaperones.

Authors:  L Lan; S Isenmann; B W Wattenberg
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

6.  The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity.

Authors:  Mark G Hinds; Martin Lackmann; Gretchen L Skea; Penny J Harrison; David C S Huang; Catherine L Day
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

7.  Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.

Authors:  D Schiffer; P Cavalla; A Migheli; M T Giordana; L Chiadò-Piat
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

8.  An internal EELD domain facilitates mitochondrial targeting of Mcl-1 via a Tom70-dependent pathway.

Authors:  Chiang-Hung Chou; Ru-Shuo Lee; Hsin-Fang Yang-Yen
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

9.  The C-terminal Domains of Apoptotic BH3-only Proteins Mediate Their Insertion into Distinct Biological Membranes.

Authors:  Vicente Andreu-Fernández; María J García-Murria; Manuel Bañó-Polo; Juliette Martin; Luca Monticelli; Mar Orzáez; Ismael Mingarro
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

10.  Intracellular localization of the BCL-2 family member BOK and functional implications.

Authors:  N Echeverry; D Bachmann; F Ke; A Strasser; H U Simon; T Kaufmann
Journal:  Cell Death Differ       Date:  2013-02-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.